Webinar No. 1: Differentiating Pancreatic Ductal Adenocarcinoma (PDAC) from individuals with symptoms suggestive of PDAC, including type II diabetes, with ROC AUC values above 0.95
Presenters: Linda Mellby, PhD and Thomas King, MD, PhD, Immunovia
0:00 Introduction1:14 IMMray™ Technology 7:30 IMMray PanCan-d for detection of stage I & II PDAC – JCO 9:42 IMMray™ PanCan-d optimization study results 15:32 Next steps 19:57 Summary 21:06 Q&A Session